Sarafidis, Pantelis
Aristotle University of Thessaloniki · Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · University of Brescia
12 papers on CoChatORCID 0000-0002-9174-4018
Most cited papers
- Verified
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension
Blood Pressure and Hypertension StudiesClinical practice guidelines implementation
Cited by 3,473
- Verified
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Sarafidis, P. A., & Τσάπας, Α. (2016) · New England Journal of Medicine
Diabetes Treatment and ManagementHeart Failure Treatment and Management
Cited by 700
- Verified
Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure Profiles
Parati, G., Ochoa, J. E., Bilo, G., Agarwal, R., Covic, A., Dekker, F. W., Fliser, D., Heine, G. H., Jager, K. J., Gargani, L., et al. (2016) · Hypertension
Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes
Cited by 112
- Verified
International Consensus on Standardized Clinic Blood Pressure Measurement – A Call to Action
Cheung, A. K., Whelton, P. K., Muntner, P., Schutte, A. E., Moran, A. E., Williams, B., Sarafidis, P., Chang, T. I., Daskalopoulou, S. S., Flack, J. M., et al. (2023) · The American Journal of Medicine
Blood Pressure and Hypertension StudiesClinical practice guidelines implementation
Cited by 96
- Verified
Hypertension in Chronic Kidney Disease Part 1: Out-of-Office Blood Pressure Monitoring: Methods, Thresholds, and Patterns
Parati, G., Ochoa, J. E., Bilo, G., Agarwal, R., Covic, A., Dekker, F. W., Fliser, D., Heine, G. H., Jager, K. J., Gargani, L., et al. (2016) · Hypertension
Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes
Cited by 76
- Verified · note
The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
Piperidou, A., Sarafidis, P., Boutou, A., Thomopoulos, C., Loutradis, C., Alexandrou, M. E., Tsapas, A., & Karagiannis, A. (2019) · Journal of Hypertension
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 72
- Verified
Sodium–glucose cotransporter-2 inhibitors and blood pressure decrease: a valuable effect of a novel antidiabetic class?
Imprialos, K. P., Sarafidis, P. A., & Karagiannis, A. I. (2015) · Journal of Hypertension
Diabetes Treatment and ManagementBlood Pressure and Hypertension Studies
Cited by 71
- Verified
Microalbuminuria
Khosla, N., Sarafidis, P. A., & Bakris, G. L. (2006) · Clinics in Laboratory Medicine
Chronic Kidney Disease and DiabetesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 62
- Verified
A comparative evaluation of various methods for microalbuminuria screening
Sarafidis, P. A., Riehle, J., Bogojevic, Z., Basta, E., Chugh, A., & Bakris, G. L. (2008) · American Journal of Nephrology
Chronic Kidney Disease and DiabetesClinical Laboratory Practices and Quality Control
Cited by 41
- Verified
Cardiovascular Protection With Sodium-Glucose Cotransporter-2 Inhibitors and Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease: A Milestone Achieved
Sarafidis, P., Papadopoulos, C. E., Kamperidis, V., Giannakoulas, G., & Doumas, M. (2021) · Hypertension
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 39
- Verified
The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: no longer a cause of concern?
Sarafidis, P. A., & Ortiz, A. (2020) · Clinical Kidney Journal
Diabetes Treatment and ManagementUrinary Tract Infections Management
Cited by 37
- Verified
Hyperkalemia in chronic kidney disease: a focus on potassium lowering pharmacotherapy
Sampani, E., Theodorakopoulou, M., Iatridi, F., & Sarafidis, P. (2023) · Expert Opinion on Pharmacotherapy
Potassium and Related DisordersParathyroid Disorders and Treatments
Cited by 11
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free